LT4295B - 14alfa, 17alfa-c2-tilteliu sujungti 19-norprogesterono dariniai - Google Patents

14alfa, 17alfa-c2-tilteliu sujungti 19-norprogesterono dariniai Download PDF

Info

Publication number
LT4295B
LT4295B LT97-106A LT97106A LT4295B LT 4295 B LT4295 B LT 4295B LT 97106 A LT97106 A LT 97106A LT 4295 B LT4295 B LT 4295B
Authority
LT
Lithuania
Prior art keywords
dione
ethane
norpregna
methyl
diene
Prior art date
Application number
LT97-106A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT97106A (en
Inventor
Klaus Schoellkopf
Wolfgang Halfbrodt
Joachim Kuhnke
Wolfgang Schwede
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Hans-Peter Muhn
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of LT97106A publication Critical patent/LT97106A/xx
Publication of LT4295B publication Critical patent/LT4295B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LT97-106A 1994-12-23 1997-06-20 14alfa, 17alfa-c2-tilteliu sujungti 19-norprogesterono dariniai LT4295B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide

Publications (2)

Publication Number Publication Date
LT97106A LT97106A (en) 1997-10-27
LT4295B true LT4295B (lt) 1998-02-25

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
LT97-106A LT4295B (lt) 1994-12-23 1997-06-20 14alfa, 17alfa-c2-tilteliu sujungti 19-norprogesterono dariniai

Country Status (33)

Country Link
US (3) US5827842A (lv)
EP (1) EP0799238B1 (lv)
JP (1) JPH10511379A (lv)
KR (1) KR100400621B1 (lv)
CN (1) CN1109689C (lv)
AR (1) AR002263A1 (lv)
AT (1) ATE193300T1 (lv)
AU (1) AU692346B2 (lv)
BG (1) BG63274B1 (lv)
CA (1) CA2208605C (lv)
CZ (1) CZ292696B6 (lv)
DE (2) DE4447401A1 (lv)
DK (1) DK0799238T3 (lv)
EE (1) EE03356B1 (lv)
ES (1) ES2151612T3 (lv)
FI (1) FI972624A (lv)
GR (1) GR3034261T3 (lv)
HU (1) HUP0600457A2 (lv)
IL (1) IL116504A (lv)
LT (1) LT4295B (lv)
LV (1) LV11954B (lv)
NO (1) NO310198B1 (lv)
NZ (1) NZ298770A (lv)
PL (1) PL182642B1 (lv)
PT (1) PT799238E (lv)
RO (1) RO119366B1 (lv)
RU (1) RU2169153C2 (lv)
SI (1) SI9520137A (lv)
SK (1) SK282281B6 (lv)
TW (1) TW333536B (lv)
UA (1) UA45382C2 (lv)
WO (1) WO1996020209A2 (lv)
ZA (1) ZA9510923B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503919B1 (ko) * 1996-09-03 2005-07-27 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 비타민 디 및 스테로이드 유도체들의 합성에 사용되는 중간체들의 제조방법
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001275A1 (en) 1986-08-20 1988-02-25 Schering Aktiengesellschaft Berlin Und Bergkamen 14,17beta-ETHANO-14beta-ESTRATRIENES AND ESTRATETRAENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001275A1 (en) 1986-08-20 1988-02-25 Schering Aktiengesellschaft Berlin Und Bergkamen 14,17beta-ETHANO-14beta-ESTRATRIENES AND ESTRATETRAENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A. J. SOLO, J. N. KAPOOR: "Ring D bridged steroid analogs. 11. High Clauberg activity of 19-nor-14.alpha.,17.alpha.-ethano-4-pregnene-3,20-dione", J. MED. CHEM., 1973, pages 270 - 273

Also Published As

Publication number Publication date
US6147065A (en) 2000-11-14
DE59508403D1 (de) 2000-06-29
EP0799238A2 (de) 1997-10-08
BG63274B1 (bg) 2001-08-31
AU4433896A (en) 1996-07-19
UA45382C2 (uk) 2002-04-15
CA2208605C (en) 2008-07-15
CA2208605A1 (en) 1996-07-04
ATE193300T1 (de) 2000-06-15
DE4447401A1 (de) 1996-07-04
RO119366B1 (ro) 2004-08-30
ZA9510923B (en) 1996-07-04
MX9704774A (es) 1997-10-31
JPH10511379A (ja) 1998-11-04
LV11954A (lv) 1998-01-20
FI972624A0 (fi) 1997-06-18
LT97106A (en) 1997-10-27
SK78897A3 (en) 1997-12-10
KR100400621B1 (ko) 2004-02-05
US5973172A (en) 1999-10-26
BG101554A (en) 1998-09-30
NZ298770A (en) 1999-10-28
CN1171115A (zh) 1998-01-21
IL116504A (en) 2001-11-25
PT799238E (pt) 2000-11-30
IL116504A0 (en) 1996-03-31
EP0799238B1 (de) 2000-05-24
US5827842A (en) 1998-10-27
AR002263A1 (es) 1998-03-11
DK0799238T3 (da) 2000-10-09
WO1996020209A2 (de) 1996-07-04
GR3034261T3 (en) 2000-12-29
NO972927L (no) 1997-08-22
LV11954B (lv) 1998-06-20
WO1996020209A3 (de) 1996-09-06
HUP0600457A2 (en) 2006-08-28
PL182642B1 (pl) 2002-02-28
AU692346B2 (en) 1998-06-04
PL320799A1 (en) 1997-10-27
CZ195497A3 (cs) 1998-03-18
NO310198B1 (no) 2001-06-05
ES2151612T3 (es) 2001-01-01
FI972624A (fi) 1997-06-18
CN1109689C (zh) 2003-05-28
TW333536B (en) 1998-06-11
SK282281B6 (sk) 2002-01-07
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
NO972927D0 (no) 1997-06-23
CZ292696B6 (cs) 2003-11-12
EE03356B1 (et) 2001-02-15

Similar Documents

Publication Publication Date Title
JP3462515B2 (ja) １７−スピロフラン−３′−イリデンステロイド
KR100402636B1 (ko) 17-스피로메틸렌락톤또는락톨기를갖는스테로이드
JP2003515543A (ja) １４，１５−ベータ−メチレン置換されたアンドロゲン
JP2010529153A (ja) １７β−シアノ−１９−ノル−アンドロスタ−４−エン誘導体、その使用、及び当該誘導体を含む医薬
LT4295B (lt) 14alfa, 17alfa-c2-tilteliu sujungti 19-norprogesterono dariniai
AU677019B2 (en) Gestagenically active 19,11-bridged 4-estrenes
DE60004377T2 (de) Oral wirksame 7-alpha-alkyl androgene
US6881728B1 (en) 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
JP5600069B2 (ja) １７−（１’−プロペニル）−１７−３’−オキシドエストラ−４−エン−３−オン誘導体、その使用及び当該誘導体を含む医薬品
KR100730010B1 (ko) 신규 안드로겐
MXPA97004774A (en) Derivatives of 19-nor-progesterone bridged in c214alfa, 17a
WO1995011915A1 (de) 10,11β-C2-ÜBERBRÜCKTE STEROIDE
WO1995027725A1 (de) 11β,19-ÜBERBRÜCKTE 13α-ALKYLSTEROIDE

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20071223